Chicago Capital, LLC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 84 filers reported holding ALBIREO PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Chicago Capital, LLC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$29,443,284
+35.8%
1,362,484
+21.7%
1.63%
+29.9%
Q3 2022$21,679,000
-19.2%
1,119,774
-17.1%
1.25%
-15.4%
Q2 2022$26,836,000
-11.1%
1,351,234
+33.6%
1.48%
+14.2%
Q1 2022$30,180,000
+52.6%
1,011,744
+19.1%
1.30%
+76.3%
Q4 2021$19,779,000
-22.7%
849,239
+3.6%
0.74%
-24.0%
Q3 2021$25,576,000
+4.3%
819,738
+17.6%
0.97%
+1.1%
Q2 2021$24,529,000
+1.4%
697,236
+1.6%
0.96%
-6.1%
Q1 2021$24,193,000
+4.3%
686,338
+11.0%
1.02%
-1.4%
Q4 2020$23,191,000
+36.2%
618,263
+21.1%
1.04%
+18.3%
Q3 2020$17,033,000
+28.0%
510,443
+1.6%
0.88%
+13.6%
Q2 2020$13,304,000
+64.9%
502,212
+1.9%
0.77%
+18.4%
Q1 2020$8,068,000
+81.1%
492,878
+181.2%
0.65%
+139.3%
Q4 2019$4,456,000
+0.1%
175,289
-21.2%
0.27%
-8.7%
Q3 2019$4,451,000
-31.7%
222,549
+10.0%
0.30%
-28.5%
Q2 2019$6,520,000
+6.9%
202,241
+6.8%
0.42%
+0.5%
Q1 2019$6,101,000
+37.5%
189,408
+4.7%
0.42%
+14.6%
Q4 2018$4,438,000
-16.0%
180,911
+12.9%
0.36%
-0.8%
Q3 2018$5,282,000
+10.4%
160,248
+18.9%
0.36%
-5.4%
Q2 2018$4,784,000
+61.7%
134,748
+48.4%
0.39%
-2.3%
Q1 2018$2,958,00090,8310.40%
Other shareholders
ALBIREO PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Perceptive Advisors 1,704,330$60,504,0001.59%
Birchview Capital, LP 38,000$1,349,0000.92%
Virtus ETF Advisers LLC 24,688$876,0000.77%
BVF INC/IL 220,000$7,810,0000.76%
SECTORAL ASSET MANAGEMENT INC 172,803$6,135,0000.69%
Chicago Capital, LLC 134,748$4,784,0000.39%
Artal Group S.A. 500,000$17,750,0000.38%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$25,432,0000.33%
Eversept Partners, LP 18,029$640,0300.29%
HEARTLAND ADVISORS INC 125,000$4,438,0000.29%
View complete list of ALBIREO PHARMA INC shareholders